Ambrosia Brands LLC initiated this supplements recall on February 13, 2026. The FDA enforcement report states: Product may be contaminated with Salmonella. The FDA report lists distribution as: Nationwide in the United States, including American Samoa, Northern Mariana Islands, Puerto Rico, and Virgin Islands. International distribution to consumers in: Algeria, Anguilla, Australia, Austria, Bahrain, Belgium, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Canada, Chile, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Egypt, Estonia, Faroe Islands, Finland, France, French Polynesia, Georgia, Germany, Gibraltar, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Lithuania, Luxembourg, Malaysia, Malta, Marshall Islands, Mexico, Nauru, New Zealand, Netherlands, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Suriname, Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago, Turkey, United Arab Emirates, United Kingdom, Venezuela, and Zimbabwe.
The FDA enforcement report describes the reason as: Product may be contaminated with Salmonella
Rosabella Brand Moringa was made or distributed by Ambrosia Brands LLC in New York, NY, United States. This page reflects FDA report H-0546-2026, dated March 18, 2026.